Difference between revisions of "VEGFR-2"
m |
m |
||
| Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
| − | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
|- | |- | ||
| align="center" colspan="2" bgcolor="#ffffff" | | | align="center" colspan="2" bgcolor="#ffffff" | | ||
| Line 47: | Line 47: | ||
translocation of VEGFR-2 into the nucleus | translocation of VEGFR-2 into the nucleus | ||
|- | |- | ||
| − | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
[[Category:Tissue transglutaminase|*]] | [[Category:Tissue transglutaminase|*]] | ||
Latest revision as of 12:01, 10 March 2015
| VEGFR-2 | |
|---|---|
| Substrate peptide name | VEGFR-2 |
| Synonyms | - |
| Determination type | In situ |
| Source | Homo sapiens |
| Subcellular localization | Plasma membrane, nucleus |
| Swissprot ID | P35968 |
| Reactive glutamines | Not determined yet |
| Reactive lysines | - |
| Substrate sequence | |
| Structure | 1Y6A |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:16914140 |
| Notes | Blocking the transglutaminase activity of TG2 prevents the VEGF-induced
translocation of VEGFR-2 into the nucleus |
